bpc 157 safety concerns fda warning FDA's Overreach on Compounded Peptides bpc-157 safety fda warning peptides

Experimental Dermatology, 20 (4), 297-302

Periodic boundary conditions were used with a cutoff of 10 for non-bonded interactions and the Particle Mesh Ewald method for long-range electrostatics

50 mg / 5 mL = 10 mg/mL 2,000 mcg / 10,000 mcg per mL = 0.2 mL = 20 U-100 units 1,000 mcg / 10,000 mcg per mL = 0.1 mL = 10 U-100 units GHK-Cu 100 mg vial with 5 mL example A larger 100 mg vial mixed with 5 mL gives 20 mg/mL, or 20,000 mcg/mL double the strength of the 50 mg example

Dose and cycle length for GI protocols are determined at your provider intake and adjusted based on symptom response

CONCERN #5: POOR WOUND HEALING AND SCARRING Description: A simple cut takes weeks to heal, or a surgical scar remains raised, red, and uncomfortable long after the procedure